$Evaluating the antifracture efficacy of bisphosphonates.$

Evaluating the antifracture efficacy of bisphosphonates.

Oral bisphosphonate dosing schedules have evolved from the original daily regimens to weekly (alendronate and risedronate) and monthly (risedronate and ibandronate) regimens. Intravenous (i.v.) bisphosphonates are administered less frequently-quarterly ibandronate injection and yearly zoledronic aci...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	Pazianas, M, Epstein, S, Zaidi, M
פורמט:	Journal article
שפה:	English
יצא לאור:	2009

פריטים דומים

Antifracture agents for prostate cancer patients on androgen deprivation therapy
מאת: Bhupendra P Singh, et al.
יצא לאור: (2010-01-01)

The sequential antifracturative treatment: a meta-analysis of randomized clinical trials
מאת: Angelo Fassio, et al.
יצא לאור: (2024-04-01)

Safety of bisphosphonates.
מאת: Pazianas, M, et al.
יצא לאור: (2011)

Bisphosphonates and bone quality.
מאת: Pazianas, M, et al.
יצא לאור: (2014)

Atrial fibrillation and bisphosphonate therapy.
מאת: Pazianas, M, et al.
יצא לאור: (2010)

Potential therapeutic effects of oral bisphosphonates on the intestine.
מאת: Pazianas, M, et al.
יצא לאור: (2011)

Safety issues with bisphosphonate therapy for osteoporosis.
מאת: Suresh, E, et al.
יצא לאור: (2014)

Are bisphosphonates associated with an increased risk of atypical femoral fractures as a class?
מאת: Pazianas, M
יצא לאור: (2013)

Cardiovascular Safety of Antifracture Medications in Patients With Osteoporosis: A Narrative Review of Evidence From Randomized Studies
מאת: Alexander J Rodríguez, et al.
יצא לאור: (2022-06-01)

Cardiovascular Safety of Antifracture Medications in Patients With Osteoporosis: A Narrative Review of Evidence From Randomized Studies
מאת: Alexander J Rodríguez, et al.
יצא לאור: (2021-07-01)

Bisphosphonates and colon cancer: reply.
מאת: Pazianas, M, et al.
יצא לאור: (2013)

Bisphosphonates and colon cancer: Reply
מאת: Pazianas, M, et al.
יצא לאור: (2013)

Eliminating the need for fasting with oral administration of bisphosphonates.
מאת: Pazianas, M, et al.
יצא לאור: (2013)

Eliminating the need for fasting with oral administration of bisphosphonates
מאת: Pazianas M, et al.
יצא לאור: (2013-10-01)

NE‐58025: A bisphosphonate with a low hydroxyapatite binding affinity
מאת: Michael Pazianas
יצא לאור: (2021-08-01)

Atrial fibrillation and the use of oral bisphosphonates.
מאת: Pazianas, M, et al.
יצא לאור: (2011)

Atrial fibrillation and the use of oral bisphosphonates
מאת: Michael Pazianas, et al.
יצא לאור: (2011-03-01)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.
מאת: Pazianas, M, et al.
יצא לאור: (2010)

Findings of Danish study on risk of colon cancer in bisphosphonate users were misinterpreted.
מאת: Abrahamsen, B, et al.
יצא לאור: (2013)

NO ASSOCIATION BETWEEN THE USE OF ORAL BISPHOSPHONATES AND INCIDENCE OF ATRIAL FIBRILLATION
מאת: Pazianas, M, et al.
יצא לאור: (2010)

Comment on Tadrous et al.: comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis.
מאת: Pazianas, M, et al.
יצא לאור: (2014)

Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker.
מאת: Pazianas, M, et al.
יצא לאור: (2008)

Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker: Reply to Yarom and Elad
מאת: Pazianas, M, et al.
יצא לאור: (2008)

A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
מאת: Pazianas, M, et al.
יצא לאור: (2007)

Impact of bisphosphonates in age-related macular degeneration: Retrospective cohort and nested case-control study
מאת: Garriga, C, et al.
יצא לאור: (2018)

Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study.
מאת: Pazianas, M, et al.
יצא לאור: (2012)

Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: cohort analysis using a national prescription database.
מאת: Pazianas, M, et al.
יצא לאור: (2013)

Oral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
מאת: Garriga, C, et al.
יצא לאור: (2018)

Impact of bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
מאת: Garriga, C, et al.
יצא לאור: (2018)

Bisphosphonates and Age-Related Macular Degeneration: A Propensity-Matched Cohort and Nested Case-Control Analysis
מאת: Garriga, C, et al.
יצא לאור: (2017)

Bisphosphonates
מאת: Bishop, N, et al.
יצא לאור: (2013)

Bisphosphonates
מאת: Fırat Öztürk
יצא לאור: (2009-04-01)

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
מאת: Russell, R, et al.
יצא לאור: (2007)

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
מאת: Russell, R, et al.
יצא לאור: (2007)

Safety and efficacy of bisphosphonates in thalassemia patients with osteopenia/osteoporosis
מאת: Sujata Sharma, et al.
יצא לאור: (2023-04-01)

Efficacy of Bisphosphonates for the Treatment of Osteoporosis in Patients with Multiple Sclerosis
מאת: İlke Coşkun Benlidayı, et al.
יצא לאור: (2015-08-01)

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.
מאת: Russell, R, et al.
יצא לאור: (2008)

Bisphosphonates: An update
מאת: Nalliappan Ganapathy, et al.
יצא לאור: (2012-01-01)

Bisphosphonates 2006
מאת: Russell, R
יצא לאור: (2006)

Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: a register-based cohort study using the US MarketScan claims databases.
מאת: Pazianas, M, et al.
יצא לאור: (2012)